Cardiac ischemia and reperfusion in spontaneously diabetic rats with and without application of EGb 761: II. Interstitium and microvasculature

Histology and Histopathology

Volumn 24, Issue 5, 2009, Pages 587-598

  Schneider, Rick ^a   Welt, Klaus ^a   Aust, Wolfram ^a   Löster, Heinz ^a   Fitzl, Günther ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Diabetes; EGb 761; Interstitium; Ischemia; Microvessels

Indexed keywords

ANIMALIA; GINKGO BILOBA; RATTUS;

CARDIOVASCULAR AGENT; COLLAGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GINKGO BILOBA EXTRACT 761; NOS3 PROTEIN, RAT; PLANT EXTRACT; SCAVENGER; SUBSTANCE P;

ANIMAL; ARTICLE; BIOBREEDING RAT; DIABETES MELLITUS; DRUG EFFECT; GINKGO BILOBA; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; MICROCIRCULATION; PATHOLOGY; PHYTOTHERAPY; RAT; REPERFUSION INJURY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CARDIOVASCULAR AGENTS; COLLAGEN; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FREE RADICAL SCAVENGERS; GINKGO BILOBA; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MICROSCOPY, ELECTRON, TRANSMISSION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, INBRED BB; SUBSTANCE P;

EID: 67149121983     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Aragno M., Mastrocola R., Alloatti G., Vercellinatto I., Bardini P., Geuna S., Catalano M.G., Danni O. and Boccuzzi G. (2008). Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 149, 380-388.
2. Bäcklund T., Palojoki E., Saraste A., Eriksson A., Finckenberg P., Kytö V., Lakkisto P., Mervaala E., Voipio-Pulkki L.M., Laine M. and Tikkanen I. (2004). Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes. Diabetologia 47, 325-330.
3. Bollano E., Omerovic E., Svensson H., Waagstein F. and Fu M. (2007). Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats. Int. J. Cardiol. 114, 195-201.
4. Brownlee M. (1995). Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46, 223-234.
5. Burton K.P., Morris A.C., Massey K.D., Buja L.M. and Hagler H.K. (1990). Free radicals alter ionic calcium levels and membrane phospholipids in cultured rat ventricular myocytes. J. Mol. Cell. Cardiol. 22, 1035-1047.
6. Chiao H. and Caldwell R.W. (1996). The role of substance P in myocardial dysfunction during Ischaemia and reperfusion. Naunyn Schmiedebergs Arch. Pharmacol. 353, 400-407.
7. Cleutjens J.P., Kandala J.C., Guarda E., Guntaka R.V. and Weber K.T. (1995). Regulation of collagen degradation in the rat myocardium after infarction. J. Mol. Cell. Cardiol. 27, 1281-1292.
8. Coleman J.W., Huang Q. and Stanworth D.R. (1986). The mast cell response to substance P: Effects of Neuraminidase, Limulin, and some novel synthetic peptide antagonists. Peptides 7, 171-175.
9. Consentino F. and Luscher T. (1998). Endothelial dysfunction in diabetes mellitus. J. Cardiovasc. Pharmacol. 32, 54-61.
10. Crivellato E., Damiani D., Mallardi F. and Travan L. (1991). Suggestive evidence for a microanatomical relationship between mast cells and nerve fibres containing substance P, calcitonin gene ralated peptide, vasoactive intestinal polypeptide, and somatostatin in the rat mesentery. Acta Anat. 141, 127-131.
11. DaTorre S.D., Creer M.H., Pogwizd S.M. and Corr P.B. (1991). Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J. Mol. Cell. Cardiol. 23, 11-22.
12. Denk D., Kuenzle H. and Plenk H. (1989). Schnellfärben von Semidünnschnitten. In: Mikroskopische Technik. Boeck P. (ed). Urban & Schwarzenberg. München. pp 247-248.
13. Desjardins F. and Balligand J.L. (2006). Nitric oxide-dependent endothelial function and cardiovascular disease. Acta Clin. Belg. 61, 326-334.
14. Doi K., Sawada F., Toda G., Yamachika S., Seto S. and Urata Y. (2001). Alteration of antioxidants during the progression of heart disease in streptozotocin-induced diabetic rats. Free Radic. Res. 34, 251-261.
15. Factor S.M., Okun E.M., Minase T. (1980). Capillary microaneurysms in the human diabetic heart. New Engl. J. Med. 302, 384-388.
16. Fox C.C., Lazenby A.J., Moore W.C., Yardley J.H., Bayless T.M. and Lichtenstein L.M. (1990). Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 99, 119-124.
17. Giraldez R.R., Panda A., Xia Y., Sanders S.P. and Zweier J.L. (1997). Decreased nitric-oxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart. J. Biol. Chem. 272, 21420-21426.
18. Godin D.V., Wohaieb S.A., Garnett M.E. and Goumeniouk A.D. (1988). Antioxidant enzyme alterations in experimental and clinical diabetes. Mol. Cell. Biochem. 84, 223-231.
19. Goldin A., Beckman J.A., Schmidt A.M. and Creager M.A. (2006). Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury. Circulation 114, 597-605.
20. Gross M.L., Heiss N., Weckbach M., Hansen A., El-Shakmak A., Szabo A., Münter K., Ritz E. and Amann K. (2004). ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes. Diabetologia 47, 316-324.
21. Huang M.T., Johnson E.F., Muller-Eberhard U., Koop D.R., Coon M.J. and Conney A.H. (1981). Specificity in the activation and inhibition by flavonoids of benzo[a]pyrene hydroxylation by cytochrome P-450 isozymes from rabbit liver microsomes. J. Biol. Chem. 256, 10897-10901.
22. Janssens D., Michiels C., Delaive E., Eliaers F., Drieu K. and Remacle J. (1995). Protection of hypoxia-induced ATP decrease in endothelial cells by ginkgo biloba extract and bilobalide. Biochem. Pharmacol. 50, 991-999.
23. Kakkar R., Kalra J., Mantha S.V. and Prasad K. (1995). Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol. Cell. Biochem. 151, 113-9.
24. Kantengwa S. and Polla B.S. (1991). Flavonoids, but not protein kinase C inhibitors, prevent stress protein synthesis during erythrophagocytosis. J. Clin. Invest. 95, 677-685.
25. Liebgott T., Miollan M., Berchadsky Y., Drieu K., Culcasi M. and Pietri S. (2000). Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of ginkgo biloba extract (EGb 761) during ischemia and reperfusion. Basic. Res. Cardiol. 95, 368-377.
26. Ma G., Al-Shabrawey M., Johnson J.A., Datar R., Tawfik H.E., Guo D., Caldwell R.B. and Caldwell R.W. (2006). Protection against myocardial ischemia/reperfusion injury by short-term diabetes: enhancement of VEGF formation, capillary density, and activation of cell survival signalling. Naunyn-Schmiedeberg's Arch. Pharmacol. 373, 415-427.
27. Maitra I., Marcocci L., Droy-Lefaix M.T. and Packer L. (1995). Peroxyl radical scavenging activity of ginkgo biloba extract EGb 761. Biochem. Pharamcol. 49, 1649-1655.
28. Marcocci L., Maguire J.J., Droy-Lefaix M.T. and Packer L. (1994). The nitric oxide-scavenging properties of ginkgo biloba extract EGb 761. Biochem. Biophys. Res. Commun. 201, 748-755.
29. Marisa C., Lucci I., Di Giulio C., Bianchi G., Grilli A., Patruno A. and Reale M. (2005). MCP-1 and MIP-2 expression and production in BB diabetic rat: Effect of chronic hypoxia. Mol. Cell. Biochem. 276, 105-111.
30. McDonagh P.F., Hokama J.Y., Copeland J.G. and Reynolds J.M. (1997). The blood contribution to early myocardial reperfusion injury is amplified in diabetes. Diabetes 56, 1859-1867.
31. Nagareddy P.R., Xia Z., McNeill J.H. and MacLeod K.M. (2005). Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocininduced diabetes. Am. J. Physiol. Heart. Circ. Physiol. 289, 2144-2152.
32. Okruhlicova L., Tribulova N., Weismann P. and Sotnikova R. (2005). Ultrastructure and histochemistry of rat myocardial capillary endothelial cells in response to diabetes and hypertension. Cell. Res. 15, 532-538.
33. Patella V., Genovese A. and Marone G. (1995). What are human heart mast cells for? Chem. Immunol. 62, 171-186.
34. Pieper G.M. (1999). Enhanced, unaltered and impaired nitric oxidemediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 42, 204-213.
35. Pietri S., Maurelli E., Drieu K. and Culcasi M. (1997). Cardioprotective and anti-oxidant effects of the terpenoid constituents of ginkgo biloba extract (EGb 761). J. Mol. Cell. Cardiol. 29, 733-742.
36. Pozo-Navas B., Stessel H., Wölkart G. and Brunner F. (2006). Role of Myocardial Nitric Oxide in Diabetic Ischemia-Reperfusion Dysfunction: Studies in Mice with Myocyte-Specific Overexpression of Endothelial Nitric-Oxide Synthase. JPET 319, 729-738.
37. Punkt K., Adams V., Linke A. and Welt K. (1997). The correlation of cytophotometrically and biochemically measured enzyme activities: changes in the myocardium of diabetic and hypoxic diabetic rats, with and without ginkgo biloba extract treatment. Acta Histochem. 99, 291-299.
38. Rösen P., Kiesel U. and Reinauer H. (1991). Cardiopathy in the spontaneously diabetic (BB)rat. In: The diabetic heart. Nagano M., Dhalla N.S. (eds). Raven Press. NY. pp 145-157.
39. Rösen P., Ballhausen T., Bloch W. and Addicks K. (1995). Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of Tocopherol as antioxidant. Diabetologia 38, 1157-1168.
40. Schneider R., Welt K., Aust W., Löster H. and Fitzl G. (2008). Cardiac Ischemia and Reperfusion in Spontaneously Diabetic Rats with and without Application of EGb 761: I. Cardiomyocytes. Histol. Histopathol. 23, 807-817.
41. Seibold J.R., Giorno R.C. and Claman H.N. (1990). Dermal mast cells degranulation in systemic sclerosis. Arthritis Rheum. 33, 1702-1709.
42. Sexton W.L., Poole D.C. and Mathieu-Costello O. (1994). Microvasculatory structure-function relationships in skeletal muscle of diabetic rats. Am. J. Physiol. 266, 1502-1511.
43. Shattock M.J. (1997). Myocardial stunning: do we know the mechanism. Basic Res. Cardiol. 92, 18-22.
44. Shehadeh A. and Regan T.J. (1995). Cardiac consequences of diabetes mellitus. Clin. Cardiol. 18, 301-305.
45. Suzuki R., Furuno T., McKay D.M., Wolvers D., Teshima R., Nakanishi M. and Bienenstock J. (1999). Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J. Immunol. 163, 2410-2415.
46. Steiner D.R., Gonzales N.C. and Wood J.G. (2003). Mast cells mediate the microvascular inflammatory response systemic hypoxia. J. Appl. Physiol. 94, 325-334.
47. Swynghedauw B. (1999). Molecular mechanisms of myocardial remodelling. Physiol. Rev. 79, 215-262.
48. Taniguchi N., Arai K. and Kinoshita N. (1989). Glycation of copper/zinc superoxide dismutase and its inactivation: identification of glycated sites. Methods Enzymol. 179, 570-581.
49. Tejero-Taldo M.I., Kramer J.H., Mak I.T., Komarov A.M. and Weglicki W.B. (2006). The nerve-heart connection in the pro-oxidant response to Mg-deficiency. Heart Fail. Rev. 11, 35-44.
50. Tosaki A., Engelman D.T., Pali T., Engelman R.M. and Droy-Lefaix M.T. (1994). Ginkgo biloba extract (EGb 761) improves postischemic function in isolated preconditioned working rat hearts. Coron. Artery Dis. 5, 443-450.
51. Varga E., Bodi A., Ferdinandy P., Droy-Lefaix M.T., Blasig I.E. and Tosaki A. (1999). The protective effect of EGb 761 in isolated ischemic/reperfused rat hearts: a link between cardiac function and nitric oxide production. J. Cardiovasc. Pharmacol. 34, 711-717.
52. Warley A., Powell J.M. and Skepper J.N. (1995). Capillary surface area is reduced and tissue thickness from capillaries to myocytes is increased in the left ventricle of streptozotocin-diabetic rats. Diabetologia 38, 413-421.
53. Welt K., Weiss J., Koch S. and Fitzl G. (1999). Protective effects of ginkgo biloba extract EGb 761 on the myocardium of experimentally diabetic rats. Exp. Toxicol. Pathol. 51, 213-222.
54. Welt K., Fitzl G. and Schepper A. (2001). Experimental hypoxia of STZdiabetic rat myocardium and protective effects of ginkgo biloba extract. II. Ultrastructural investigation of microvascular endothelium. Exp. Toxicol. Pathol. 52, 503-512.
55. Yu J.Z., Rodrigues B. and McNeill J.H. (1997). Intracellular calcium levels are unchanged in the diabetic heart. Cardiovasc. Res. 34, 91-98.
56. Zatz R. and Brenner B.M. (1986). Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am. J. Med. 80, 443-453.
57. Zhao G., Zhang X., Smith C.J., Xu X., Ochoa M., Greenhouse D., Vogel T., Curran C. and Hintze T.H. (1999). Reduced coronary NO production in conscious dogs after the development of alloxaninduced diabetes. Am. J. Physiol. 277, 268-278.
58. Zhang X.M., Shen F., Xv Z.Y., Yan Z.Y. and Han S. (2005). Expression changes of thrombospondin-1 and neuropeptide Y in myocardium of STZ-induced rats. Int. J. Cardiol. 105, 192-197.
59. Zweier J., Fertmann J. and Wei G. (2001). Nitric oxide and peroxynitrite in postischemic myocardium. Antioxid. Redox. Signal. 3, 11-22.